We have studied the concentrations of intact human choriogonadotropin (hCG) and the free hCG 13-subunit in blood samples from singleton pregnancies at risk for habitual or threatened abortion. The samples were obtained weekly between the 6th and 12th weeks and in the 14th and 16th weeks of gestational age. The concentrations of intact hCG, of the free hCG /3-subunit, and of "total" hCG (i.e., intact hCG and the free hCG /3-subunit: hCG + /3)were measured in serum by specific immunoassays. The distributional statistics (the 5th, 50th, and 95th percentiles) of "total" hCG + /3and of intact hCG showed very similar patterns, whereas the response curves for the free hCG /3-subunit showed very much lower serum concentrations. From these data we also estimated distributional statistics of the percent molar ratios of free hCG /3-subunit to intact hCG. We conclude that (a) the relatively small proportion of free hCG /3-subunit in serum during the first half of singleton pregnancy is far too low to interfere with the applied "total" hCG assay, as compared with the serum values obtained for intact hCG, and (b) the percent molar ratios of free hCG /3-subunit to intact hCG, or to "total" hCG + /3, never exceeded 1.0% throughout the period of pregnancy studied.
and the free /3-subunit (hCG + /3)(2, 3). However, the relative concentrations of these are usually unknown, and there is evidence for considerable heterogeneity of hCG and its subunits both in pregnancy (4) and in cases of hCGsecreting tumors (5). The development of assays specific to intact hCG and to the free /3-subunit has permitted us to examine the concentrations of these hormones in the blood of patients during early pregnancy and to compare these 'Department of Obstetrics and Gynaecology, Division of Gynaecologic Endocrinology and Infertility, and Laboratory of Endocrinology and Reproduction, Sint-Radboud Hospital, Catholic University Nijmegen, P.O. Box 9101, 6500 RB Nijmegen, The Netherlands.
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with "total" hCG + (3 measurements in the same samples. From these data, we have also calculated the percent molar ratio of the free hCG /3-subunit to intact hCG, a ratio reported to have prognostic significance for persistent trophoblastic disease in molar pregnancy (6, 7) .
MaterIals and Methods Patients
Twenty-seven patients at risk for habitual or threatened abortion gave informed consent to the collection of blood specimens from the cubital vein at each weekly visit between weeks 6 and 12 of "menstrual age" (time since ovulation plus two weeks) and afterwards in weeks 14 and 16. Samples were collected in the afternoon, centrifuged, and stored at -20 #{176}C until assayed. As detailed elsewhere (8), selection criteria for the subjects were as follows: pregnancy after induction of ovulation, or infertility for more than one year, or two or more previous spontaneous abortions (proven histologically, or by a positive pregnancy test).
Immunoassays
We used the Enzymun-Test5HCG
(Boehringer Mannhelm GmbH, Mannheim, F.R.G.) to measure "total" hCG, i.e., intact hCG and its free /3-subunit, hCG + /3in serum, and the Tandem#{174} IEMAs of intact hCG, but was quite substantial in the IEMA of hCG + /3[reported mean cross-reactivity 231% (3)].
Radioimmunoassay.
The RIA for free hCG /3-subunit utilizes an MAb against hCG/3 (cat. no. 0772; Hybritech Europe) (9), a highly purified hCGp preparation labeled with 1251 (2) 
Statistics
Throughout the period of observation (weeks 6-16), we determined the longitudinal patterns ("response curve") for each hCG-parameter: "total" hCG + (3, intact hCG, and free hCG /3-subunit. Distribution statistics (the 5th, 50th, and 95th percentiles) were calculated separately for each week, for the serum concentrations of each hCG variable and for the molar ratio of free hCG (3-subunit to intact hCG, after log-transformation (11, 12) and subsequent pooling (over the weeks) of variances.
Results
Figure Table 2) clearly demonstrate an almost absolute similarity between the "intact" hCG and the "total" hCG + /3 distribution in our subjects; hence the data for "total" hCG + 13were
omitted from Figure 2 . Although all the hCG distribution statistics, including the calculated molar ratios, show almost identical patterns, the values for intact hCG and "total" hCG + flare substantially higher than the much lower values for the free hCG /3-subunit.
DIscussIon
We have developed an RIA for quantifying free hCG /3-subunit in serum, which we have used, concurrently with two commercial IEMA8, to determine the concentrations of intact hCG and intact hCG + free hCG /3-subunit ("total" hCG + /3)in serum during the first half of human singleton high-risk pregnancy. We present distribution statistics of the three hCG analytes measured during this period and have tested the relative contribution of free hCG (3-subunit to the concentrations of intact hCG vs "total" hCG + (3 measured in serum.
The developed RIA and the two other assay systems meet all the criteria for reliability. The free hCG (3-subunit RIA described here shows an apparent cross-reactivity . (6,9) , who, however, did not use 1BPs of intact hCG and its /3-subunit. The First IRP hCG reportedly contains insignificant contamination with free hCG (3-subunit (1, 10) . However, the apparent cross-reactivity of 0.55% (mollmol) for this IRP in our RIA is in contrast to our measurements of subjects' Table  2 sera. With these sera we observed a "physiological" cross- gel electrophoresis the presence of free (3-subunits of hCG in the applied hCG standard, they concluded in subsequent analyses that the cross-reactivities were due to the presence of free hCG /3-subunits in the hCG standard. Their data and our results differ from those reported by Alfthan et al. (14) , who calculated substantially higher mean molar ratios of hCG/3/hCG in serum, between 0.87% and 3.28%, until week 17 of gestation. Also, in contrast to Ozturk et al. and our report, their molar /3hCG/hCG ratios were always higher than the reported (14) true cross-reaction of 0.54% (range 0.35%-1.1%) for intact hCG in their immunofiuorometric assay of hCG(3, notably after purification of the applied intact hCG stanMolar ratio of free hCG-(3/intact hCG. % Fig. 3 . Frequency distributionof the percent molar ratios of free hCG (3-subunit/intacthCG as measuredin 223 pregnancy sera The line, representing the cumulative frequency distribution(%))shows thatas much as 93.7% of all the serum samplestested have a free hCG fisubunit/intact hCG molarratiobelowthe 0.55% cross-reactivityobtained for the WHO FirstlAP of intact hCG 75/537 in the free hCG p-subunit RIA dard with hydrophobic-interaction chromatography. We conclude that our applied free hCG /3-subunit RIA is well suited to determine the concentrations of free hCG (3- subunit in serum in the presence of huge amounts of intact hCG, as has been demonstrated now with physiologic sera.
In conclusion: the measurement of the free hCG /3-subunit offers no clinical utility over measurement of intact hCG, or of total hCG + /3during the first half of pregnancy; the distribution statistics of hCG values in serum in the first half of pregnancy are identical and irrespective of the applied type of hCG assay system (intact hCG, or "total" hCG + (3); and the very much lower concentrations of free hCG (3-subunit in serum (i.e., <0.55% of intact hCG, mol/mol) do not interfere with these hCG assays. Also, the described RIA of free hCG /3-subunit is specific and confirms the reported very low contamination of the WHO First IRP hCG with free hCG (3-subunit. Finally, the distributional statistics of the molar ratio of free hCG (3-subunit to intact hCG as estimated throughout the first half of pregnancy permits us to easily assess the prognostic significance of excessive production of the free hCG (3- subunit in the same period of pathological pregnancy.
